Emile Bienvenu

Prof. Emile holds a B. Pharm, a Master’s degree (Pharmacology) from University of the Western Cape in South Africa, and a PhD (Medical Science) from the University of Gothenburg in Sweden in the area of Clinical Pharmacology. Prof.Emile BIENVENU has been the Director General of Rwanda FDA since August 2021. Associate Professor of Pharmacology, he previously worked at University of Rwanda (1998 – 2021), where he served as Acting Deputy Vice Chancellor for Academic Affairs and Research (2020-2021), University Director for Innovation (2017-2020), and Executive Secretary for the University Research Office for six years (2002 to 2008). He also served as External Examiner at Muhimbili University of Health & Allied Sciences in Tanzania until 2016. From July 2011 until May 2013 he was the Head of Medical Procurement Division at Rwanda Biomedical Center. Dr. Emile served as the Chairman of the Board of Directors of Rwanda Standards Board (RSB) for 11 years (2009 – 2020) and served as a Member of the Board of Directors at Rwanda Military Hospital (2012-2018). Prof. Emile is an expert in hospital Drug & Therapeutic Committees (DTCs). He provided technical assistance as a resource person to the Ministry of Health in Rwanda (2006) in formulating the first editions of the Standard Treatment Guidelines and Drug Formulary. His research focuses on therapy optimization based on pharmacokinetic and pharmacogenetic considerations. He is the Country Principal Investigator of various research and innovation projects, and has authored a number of papers in peer-reviewed international Journals.